T. Rowe Price Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102M | Buy |
466,434
+4,361
| +0.9% | +$954K | 0.06% | 277 |
|
|
2025
Q1 | $103M | Sell |
462,073
-271,189
| -37% | -$60.7M | 0.07% | 272 |
|
|
2024
Q4 | $240M | Sell |
733,262
-106,048
| -13% | -$34.7M | 0.15% | 153 |
|
|
2024
Q3 | $252M | Sell |
839,310
-282,675
| -25% | -$84.8M | 0.15% | 157 |
|
|
2024
Q2 | $370M | Buy |
1,121,985
+35,960
| +3% | +$11.8M | 0.23% | 106 |
|
|
2024
Q1 | $430M | Sell |
1,086,025
-158,775
| -13% | -$62.8M | 0.26% | 101 |
|
|
2023
Q4 | $438M | Sell |
1,244,800
-381,064
| -23% | -$134M | 0.29% | 103 |
|
|
2023
Q3 | $610M | Sell |
1,625,864
-101,075
| -6% | -$37.9M | 0.43% | 65 |
|
|
2023
Q2 | $661M | Buy |
1,726,939
+7,011
| +0.4% | +$2.68M | 0.45% | 62 |
|
|
2023
Q1 | $596M | Sell |
1,719,928
-44
| -0% | -$15.2K | 0.43% | 61 |
|
|
2022
Q4 | $405M | Buy |
1,719,972
+12,228
| +0.7% | +$2.88M | 0.31% | 93 |
|
|
2022
Q3 | $420M | Buy |
+1,707,744
| New | +$420M | 0.34% | 83 |
|